Are HBOTs for Hospitals or Residential Use?

According to expert statistics, the global application of HBOT machines is expected to increase by 6.5% in four years. There are more HBOT machines in the world now than you can imagine. Several factors drive the hyperbaric oxygen therapy market at an incredible pace.

Hyperbaric oxygen therapy chambers are designed for different reasons, depending on the brand and type you are buying. For example, is it possible to get one for personal use, or must you visit a hospital to access such high-pressure machines? This post will reveal what you need to know in this regard.


HBOT, or hyperbaric oxygen therapy, is a kind of non-invasive treatment for speeding up the healing of damaged tissues. The therapy utilizes increased pressure to drive pure oxygen around the user’s body. The pressure is slightly higher than standard atmospheric pressure. The availability of abundant blood oxygen helps to combat foreign bodies in the user’s bloodstream. That is how HBOT can promote healing.

HBOT for Hospitals or Personal Use?

Many people are confused about the use of HBOT. I am sure some are just hearing it for the first time. Hyperbaric oxygen therapy is an advanced form of oxygen therapy. Think of it as the use of pure oxygen to ensure a healthy life.

HBOT machines exist in different designs and models. Some of them are designed to be used in health facilities. At the same time, some are specifically built for personal use. Therefore, hyperbaric chambers are not exclusively built for hospitals alone. Neither are they designed for personal use only. Where you intend to use your high-pressure machine is what determines the HBOT chamber type you will go for. But rest assured that you can find one that has been designed to meet your needs.


What Illnesses Can Be Treated By HBOT?

The number of sicknesses that HBOT chambers can treat is shrouded in controversies. It is still being determined which conditions can be handled by an HBOT unit. Some reports state it can treat health anomalies such as diabetes, crush injury, etc.

However, your main reason for purchasing HBOT chambers should be for something other than treatment. Instead, let it be that you are buying it for prevention reasons. Optimizing your HBOT unit allows you to live a healthier life. In hospitals, they are used chiefly for stabilizing users in delicate situations.


If your basic reason for buying a hyperbaric chamber is to treat certain illnesses on your own, you may be disappointed. However, HBOT provides you with an easy means of maintaining good health.


How HBOT is Evolving

Anyone who knows the history of HBOT would agree that it was intended for managing depression sicknesses. Plus, it was also used for handling diving complications. Today, soft-shell chambers are used by mountaineers and divers.

But, all of that is gradually changing because of technological advancement in the field of HBOT. HBOT is believed to be effective in managing many other health challenges. Medical researchers and experts are working to see how they can improve the quality of lives of patients in hospitals. And HBOT chambers have been helpful in that regard.

Types of HBOT Machines

We emphasized earlier that HBOT machines are in various forms and models. The HBOT unit appropriate for you is based on specific factors. We will look into the different types of HBOT chambers in this section and what should inform your decision.

Monoplace Hyperbaric Chambers

Monoplace chambers are designed for one person at a time. Therefore, two people can’t go into the chamber simultaneously. I am sure you can find Monoplace chambers at some health facilities, even though it is more common for personal use. For instance, many people are using them in their houses today. Do you prefer to have your therapy sessions with minimal interference and supervision? Then monoplace chambers will be a great fit for you.

Multiplace Hyperbaric Chambers

The multiplace hyperbaric chambers can accommodate more than one person at a time. It is like a bigger form of monoplace chamber. Multiplace chambers are more suited for hospitals and other health facilities. Plus, multiplace chambers are better for those who need to be monitored inside the unit. Children and aged people can use multiplace chambers since they will be under supervision.

OxyHelp Hyperbaric Oxygen Therapy Chambers

Investors are flooding the HBOT chambers market. Most investors are going in because of how lucrative the chambers are. The business is recording high profits because the high-pressure machines work. It is not a scam or hype, as many people assume.

OxyHelp has remained a leading name in the HBOT community. They have been able to distinguish themselves with their high-quality machines because where you buy your HBOT chambers matters a lot.

Several publications have revealed that users’ sad experiences with HBOT chambers can be traced to low-quality machines. To put it simply, the machines needed to be better. You can avoid all of that by purchasing your HBOT machine from OxyHelp. Their hyperbaric chambers are of high quality and safe for use. Also, they have been designed with user-friendly features.

They have HBOT chambers of different types. All you need is to run through all their products and see which will suit you. Other top-notch HBOT products can be seen on other platforms.


You now have a better understanding of HBOT chambers after reading this article. This post shows us that hyperbaric chambers are designed for various purposes. You can find some in hospitals and other health facilities. Others are built to be used at home or fitness centers. OxyHelp specializes in developing HBOT chambers for home use.  If you want to use your HBOT at home, OxyHelp is where you should be looking. Check out their website to explore the different monoplace and multiplace chambers at OxyHelp.



Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“The completion of the APEX-AV Study represents an important milestone in the catheter-directed therapies CDT space for the treatment of pulmonary embolism. I sincerely thank all the investigators for their commitment and dedication,” said William Brent Keeling, MD, Associate Professor of Surgery, Department of Surgery, at the Emory University School of Medicine, and Immediate Past President, The PERT Consortium™.
The combined expertise of Cordance Medical and the Airan and Williams Labs will see NeuroAccess utilized to deliver a novel application of drug-loaded nanoparticles, providing targeted drug delivery to the brain.
Medixine prepares for 2024 with two key senior hires, VP of Operations in the U.S. and VP of Engineering in Finland. The appointments will enhance support and service to the company’s U.S.-based partners, including leading respiratory homecare provider Lincare and a major medical device manufacturer. In addition, the new hires will enable streamlined design, testing, and deployment of new product features for more patient-centric, cost and time-effective treatment of chronic conditions.
Innovent Biologics and Synaffix: Under the terms of the expanded agreement, Innovent will be responsible for the research, development, manufacturing and commercialization of new ADC candidates. Synaffix is eligible to receive an upfront payment plus potentialmilestone payments and royalties on commercial sales for each licensed target.
Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modificatio. Analysis of 72 patients treated in STK-001 clinical trials suggests that higher STK-001 drug exposure in brain leads to greater seizure reductions. Two-year data from the longest prospective natural history study of Dravet syndrome showed that, on average, patients experienced no meaningful improvement in convulsive seizure frequency and exhibited widening gaps in cognition and behavior despite treatment with the best available anti-seizure medicines.

By using this website you agree to accept Medical Device News Magazine Privacy Policy